Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 517, pseudogene (RNU6-517P), is a human pseudogene mapped to NCBI Gene ID 106479795 and Ensembl ID ENSG00000207090[4]. It is classified as a **pseudogene derived from U6 small nuclear RNA (snRNA)**. The parental U6 snRNA is a highly conserved component of the spliceosome, crucial for pre-mRNA splicing in eukaryotes, but this pseudogene copy is presumed to be non-coding and non-functional[1][5]. There are no reports assigning it any direct role in disease, molecular interactions, or use as a therapeutic target. The function of many snRNA pseudogenes, including RNU6-517P, is generally thought to be negligible, though pseudogenes can occasionally be transcribed or have regulatory functions in other cases[6]. For RNU6-517P itself, there is no evidence supporting a biological or clinical role.
Not applicable; pseudogene, no established role as a molecular target
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 517, pseudogene (RNU6-517P).